Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 2013-2018

  Rosengren, Lars E ^a   Karlsson, Jan Erik ^a   Karlsson, Jan Olof ^a   Persson, Lennart I ^a   Wikkelsø, Carsten ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; CSF; ELISA; Neurodegeneration; Neurofilament light subunit

Indexed keywords

NEUROFILAMENT PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; NEUROFILAMENT; OLIVOPONTOCEREBELLAR ATROPHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 0029828676     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67052013.x     Document Type: Article

References (27)

1. Akai K., Uchigasaki S., Tanaka H., and Komatsu A. (1987) Normal pressure hydrocephalus: neuropathological study. Acta Pathol. Jpn. 37, 97-110.
2. Angelides K. J., Smith K. E., and Takeda M. (1989) Assembly and exchange of intermediate filament proteins of neurons: neurofilaments are dynamic structures. J. Cell Biol. 108, 1495-1506.
3. Arispe N., Rojas E., and Pollard H. B. (1993) Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium. Proc. Natl. Acad. Sci. USA 90, 567-571.
4. Bergeron C., Beric-Maskarel K., Muntasser S., Weyer L., Somerville M. J., and Percy M. E. (1994) Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53, 221-230.
5. Brownell B., Oppenheimer D. R., and Hughes J. T. (1970) The central nervous system in motor neuron disease. J. Neurol. Neurosurg. Psychiatry 33, 338-357.
6. Karlsson J.-E., Rosengren L. E., and Haglid K. G. (1987) A rapid HPLC method to separate the triplet proteins of neurofilament. J. Neurochem. 49, 1375-1378.
7. Karlsson J.-E., Rosengren L. E., and Haglid K. G. (1989) Polyclonal antisera to the individual neurofilament triplet proteins: a characterization using ELISA and immunoblotting. J. Neurochem. 53, 759-765.
8. Karlsson J.-E., Rosengren L. E., and Haglid K. G. (1991) Quantitative and qualitative alterations of neuronal and glial intermediate filaments in rat nervous system after exposure to 2,5-hexanedione. J. Neurochem. 57, 1437-1444.
9. Kume A., Takahashi A., and Hashizume Y. (1993) Neuronal Joss of the striatonigral system in multiple system atrophy. J. Neurol. Sci. 117, 33-40.
10. Lasek R. J. (1988) Studying the intrinsic determinants of neuronal form and function, in Intrinsic Determinants of Neuronal Form and Function (Lasek R. J. and Black M. M., eds), pp. 1-60. Alan R. Liss, New York.
11. Lassmann H., Suchanek G., and Ozawa K. (1994) Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann. Neurol. 36 (Suppl.), S42-S46.
12. McKhann G., Drachman D., Holstein M., Katzman R., Price D., and Stadlan E. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
13. Nixon R. A. and Sihag R. K. (1991) Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci. 14, 501-506.
14. Olney J. W. (1990) Excitotoxin-mediated neuron death in youth and old age. Prog. Brain Res. 86, 37-51.
15. Pearson R. C. A., Esiri M. M., Hiorns R. W., Wilcock G. K., and Powell T. P. S. (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 82, 4531-4534.
16. Reiner A., Medina L., Figueredo-Cardenas G., and Anfinson S. (1995) Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Exp. Neurobiol. 131, 239-250.
17. Robinson C. A., Clark A. W., Parhad I. M., Fung T. S., and Bou S. S. (1994) Gene expression in Alzheimer neocortex as a function of age and pathologic severity. Neurobiol. Aging 15, 681-690.
18. Rosengren L. E., Wikkelsø C., and Hagberg L. (1994) A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J. Neurosci. Methods 51, 197-204.
19. Rosengren L. E., Lycke J., and Andersen O. (1995) Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit. J. Neurol. Sci. 133, 61-65.
20. Schlaepfer W. W., Lee C., Lee V. M.-Y., and Zimmerman U.-J. P. (1985) An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis. J. Neurochem. 44, 502-509.
21. Sobue G., Hashizume Y., Mitsuma T., and Takahashi A. (1987) Size-dependent myelinated fibre loss in the corticospinal tracts in Shy-Drager syndrome and amyotrophic lateral sclerosis. Neurology 37, 529-532.
22. Terry R. D., Peck A., DeTeresa R., Schechter R., and Horoupian D. S. (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10, 184-192.
23. Uchino A., Imada H, and Ohno M. (1990) MR imaging of wallerian degeneration in the human brainstem after ictus. Neuroradiology 32, 191-195.
24. van Swieten J. C., van den Hout J. H. W., van Ketel B. A., Hijdra A., Wokke J. H. J., and van Gijn J. (1991) Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. Brain 114, 761-774.
25. Vandermeeren M., Mercken M., Vanmechelen E., Six J., Van de Voorde A., Martin J.-J., and Cras P. (1993) Detection of τ proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 61, 1828-1834.
26. Wang S., Lees G. J., Rosengren L. E., Karlsson J.-E., Hamberger A., and Haglid K. G. (1992) Proteolysis of filament proteins in glial and neuronal cells after in vivo stimulation of hippocampal NMDA receptors. Neurochem. Res. 17, 1005-1009.
27. World Federation of Neurology Research Group on Neuromuscular Diseases (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 124 (Suppl.), 96-107.